BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 30775620)

  • 1. Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.
    Udomkarnjananun S; Kongnatthasate K; Praditpornsilpa K; Eiam-Ong S; Jaber BL; Susantitaphong P
    Kidney Int Rep; 2019 Feb; 4(2):231-244. PubMed ID: 30775620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium thiosulfate, bisphosphonates, and cinacalcet for treatment of calciphylaxis.
    Raymond CB; Wazny LD
    Am J Health Syst Pharm; 2008 Aug; 65(15):1419-29. PubMed ID: 18653812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cinacalcet versus standard treatment for chronic kidney disease: a systematic review and meta-analysis.
    Sekercioglu N; Busse JW; Sekercioglu MF; Agarwal A; Shaikh S; Lopes LC; Mustafa RA; Guyatt GH; Thabane L
    Ren Fail; 2016 Jul; 38(6):857-74. PubMed ID: 27137817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic review of sodium thiosulfate in treating calciphylaxis in chronic kidney disease patients.
    Peng T; Zhuo L; Wang Y; Jun M; Li G; Wang L; Hong D
    Nephrology (Carlton); 2018 Jul; 23(7):669-675. PubMed ID: 28603903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous Sodium Thiosulphate for Calciphylaxis of Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Wen W; Portales-Castillo I; Seethapathy R; Durant O; Mengesha B; Krinsky S; Kroshinsky D; Kalim S; Goverman J; Nazarian RM; Chitalia V; Malhotra R; Kramann R; Malhotra CK; Nigwekar SU
    JAMA Netw Open; 2023 Apr; 6(4):e2310068. PubMed ID: 37099293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis.
    McCarthy JT; El-Azhary RA; Patzelt MT; Weaver AL; Albright RC; Bridges AD; Claus PL; Davis MD; Dillon JJ; El-Zoghby ZM; Hickson LJ; Kumar R; McBane RD; McCarthy-Fruin KA; McEvoy MT; Pittelkow MR; Wetter DA; Williams AW
    Mayo Clin Proc; 2016 Oct; 91(10):1384-1394. PubMed ID: 27712637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisphosphonates in multiple myeloma: an updated network meta-analysis.
    Mhaskar R; Kumar A; Miladinovic B; Djulbegovic B
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003188. PubMed ID: 29253322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cinacalcet in patients with chronic kidney disease: a cumulative meta-analysis of randomized controlled trials.
    Palmer SC; Nistor I; Craig JC; Pellegrini F; Messa P; Tonelli M; Covic A; Strippoli GF
    PLoS Med; 2013; 10(4):e1001436. PubMed ID: 23637579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates in multiple myeloma: a network meta-analysis.
    Mhaskar R; Redzepovic J; Wheatley K; Clark OA; Miladinovic B; Glasmacher A; Kumar A; Djulbegovic B
    Cochrane Database Syst Rev; 2012 May; (5):CD003188. PubMed ID: 22592688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of cinacalcet compared with other treatments for secondary hyperparathyroidism in patients with chronic kidney disease or end-stage renal disease: a meta-analysis.
    Sun Y; Tian B; Sheng Z; Wan P; Xu T; Yao L
    BMC Nephrol; 2020 Jul; 21(1):316. PubMed ID: 32736534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of cinacalcet for the treatment of calciphylaxis in patients with chronic kidney disease: A comprehensive review.
    Deen J; Schaider H
    Australas J Dermatol; 2019 Aug; 60(3):e186-e194. PubMed ID: 30666627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological interventions for heart failure in people with chronic kidney disease.
    Lunney M; Ruospo M; Natale P; Quinn RR; Ronksley PE; Konstantinidis I; Palmer SC; Tonelli M; Strippoli GF; Ravani P
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD012466. PubMed ID: 32103487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis and treatment of calciphylaxis.
    Ong S; Coulson IH
    Skinmed; 2012; 10(3):166-70. PubMed ID: 22779099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Calciphylaxis. A call for interdisciplinary cooperation].
    Brandenburg VM; Schmitz S; Floege J; Amann K; Ketteler M
    Hautarzt; 2011 Jun; 62(6):452-8. PubMed ID: 21491129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calciphylaxis after parathyroidectomy.
    Karmegam S; Shetty A
    Hemodial Int; 2017 Oct; 21 Suppl 2():S62-S66. PubMed ID: 29064176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sodium Thiosulfate for Calciphylaxis Treatment in Patients on Peritoneal Dialysis: A Systematic Review.
    Gossett C; Suppadungsuk S; Krisanapan P; Tangpanithandee S; Thongprayoon C; Mao MA; Cheungpasitporn W
    Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37512116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of exposure to long working hours on ischaemic heart disease: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Li J; Pega F; Ujita Y; Brisson C; Clays E; Descatha A; Ferrario MM; Godderis L; Iavicoli S; Landsbergis PA; Metzendorf MI; Morgan RL; Pachito DV; Pikhart H; Richter B; Roncaioli M; Rugulies R; Schnall PL; Sembajwe G; Trudel X; Tsutsumi A; Woodruff TJ; Siegrist J
    Environ Int; 2020 Sep; 142():105739. PubMed ID: 32505014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of exposure to long working hours on stroke: A systematic review and meta-analysis from the WHO/ILO Joint Estimates of the Work-related Burden of Disease and Injury.
    Descatha A; Sembajwe G; Pega F; Ujita Y; Baer M; Boccuni F; Di Tecco C; Duret C; Evanoff BA; Gagliardi D; Godderis L; Kang SK; Kim BJ; Li J; Magnusson Hanson LL; Marinaccio A; Ozguler A; Pachito D; Pell J; Pico F; Ronchetti M; Roquelaure Y; Rugulies R; Schouteden M; Siegrist J; Tsutsumi A; Iavicoli S
    Environ Int; 2020 Sep; 142():105746. PubMed ID: 32505015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.